发明名称 (5-MEMBERED)-(5-MEMBERED) OR (5-MEMBERED)-(6-MEMBERED) FUSED RING CYCLOALKYLAMINE DERIVATIVE
摘要 <p>Disclosed is an antagonist of a melanin-concentrating hormone receptor, which is useful as a pharmaceutical agent for central nervous system diseases, cardiovascular diseases and metabolic diseases. Specifically disclosed is a compound represented by formula (I) [wherein Q represents CH or N; R1a, R1b, R1c and R1d independently represent a C1-6 alkyl, a halo-C1-6-alkyl, or the like; R2 represents a hydrogen atom, or the like; R3's independently represent a hydrogen atom, a C1-6 alkyl, or the like, or two R3's together form a bridge such as a methylene; R4a and R4b independently represent a hydrogen atom, a C1-6 alkyl, or the like; Z represents a bicyclic aromatic heterocyclic ring, or the like; Ar represents a benzene ring, or the like; m1 and m2 independently represent a number of 0, 1 or 2; and n represents an integer of 1 to 4] or a pharmaceutically acceptable salt thereof.</p>
申请公布号 WO2010013595(A1) 申请公布日期 2010.02.04
申请号 WO2009JP62727 申请日期 2009.07.14
申请人 BANYU PHARMACEUTICAL CO., LTD.;KISHINO HIROYUKI;SATO NAGAAKI;SUZUKI TAKAO 发明人 KISHINO HIROYUKI;SATO NAGAAKI;SUZUKI TAKAO
分类号 C07D401/06;A61K31/4525;A61K31/454;A61K31/4545;A61P1/00;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P3/12;A61P5/00;A61P9/00;A61P9/10;A61P11/00;A61P13/12;A61P15/06;A61P15/08;A61P17/00;A61P19/06;A61P25/00;A61P25/02;A61P25/08;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/34;A61P25/36;A61P35/00;A61P43/00;C07D401/14;C07D405/06;C07D417/06;C07D417/14;C07D471/04;C07D495/04 主分类号 C07D401/06
代理机构 代理人
主权项
地址